Player FM 앱으로 오프라인으로 전환하세요!
The COVID Chemistry of a Perfect Match for SpeeDx and SynGenis
Manage episode 319732900 series 3009792
For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned company spun out of Johnson and Johnson that develops PCR testing solutions for infectious diseases including COVID-19. In the wake of the pandemic, SpeeDx faced a constrained supply of oligonucleotides which are a critical component of their diagnostic kits. MTPConnect brokered SpeeDx an introduction to SynGenis and the rest is history in the making!
172 에피소드
Manage episode 319732900 series 3009792
For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned company spun out of Johnson and Johnson that develops PCR testing solutions for infectious diseases including COVID-19. In the wake of the pandemic, SpeeDx faced a constrained supply of oligonucleotides which are a critical component of their diagnostic kits. MTPConnect brokered SpeeDx an introduction to SynGenis and the rest is history in the making!
172 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.